VRT.CN - Veritas Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD

Veritas Pharma Inc.

2386 East Mall
Suite 101
Vancouver, BC V6T 1Z3
Canada
416-918-6785
http://www.veritaspharmainc.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter McFaddenInterim Pres, CEO & CFON/AN/AN/A
Mr. Blair C. LowtherCorp. Sec. & Independent DirectorN/AN/AN/A
Ms. Barbara J. JoeControllerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Veritas Pharma Inc., through its subsidiary, Cannevert Therapeutics Ltd. operates as a pharmaceutical and IP development company. It develops proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders. The company was formerly known as Seashore Organic Medicine Inc. and changed its name to Veritas Pharma Inc. in December 2015. Veritas Pharma Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.

Corporate Governance

Veritas Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.